MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2011 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
8.15 M |
Marktkapitalisierung |
$ 35.3 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Legend Biotech Corporation
LEGN
|
$ 18.48 | 3.99 % | $ 6.81 B | Nasdaq Global Select Market | USA |
 |
Baudax Bio
BXRX
|
- | 0.59 % | $ 63 K | Nasdaq Capital Market | USA |
 |
Calithera Biosciences
CALA
|
- | -10.95 % | $ 876 K | Nasdaq Global Select Market | USA |
 |
ChemoCentryx
CCXI
|
- | - | $ 3.74 B | Nasdaq Global Select Market,SPB | USA |
 |
Avid Bioservices
CDMO
|
- | - | $ 789 M | Nasdaq Capital Market | USA |
 |
Zosano Pharma Corporation
ZSAN
|
- | 7.23 % | $ 2.72 M | Nasdaq Global Select Market | USA |
 |
Spectrum Pharmaceuticals
SPPI
|
- | - | $ 189 M | Nasdaq Global Select Market | USA |
 |
VBI Vaccines
VBIV
|
- | -50.87 % | $ 1.09 M | Nasdaq Capital Market | USA |
 |
Moleculin Biotech
MBRX
|
$ 0.28 | 2.17 % | $ 332 K | Nasdaq Global Select Market | USA |
 |
CTI BioPharma Corp.
CTIC
|
- | - | $ 1.2 B | Nasdaq Capital Market | USA |
 |
Decibel Therapeutics
DBTX
|
- | - | $ 123 M | Nasdaq Global Select Market | USA |
 |
IVERIC bio
ISEE
|
- | - | $ 5.51 B | Nasdaq Global Select Market | USA |
 |
Myovant Sciences Ltd.
MYOV
|
- | -0.04 % | $ 2.62 B | NYSE | USA |
 |
Metacrine
MTCR
|
- | - | $ 24.2 M | Nasdaq Global Select Market | USA |
 |
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Madrigal Pharmaceuticals
MDGL
|
$ 449.74 | 0.32 % | $ 10.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Molecular Templates
MTEM
|
- | -23.43 % | $ 495 K | Nasdaq Capital Market | USA |
 |
CohBar
CWBR
|
- | -15.44 % | $ 2.2 M | Nasdaq Capital Market | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
- | - | $ 2.18 B | Nasdaq Global Select Market,SPB | USA |
 |
Entasis Therapeutics Holdings
ETTX
|
- | - | $ 105 M | Nasdaq Global Market | USA |
 |
Aptevo Therapeutics
APVO
|
$ 1.62 | 0.58 % | $ 511 K | Nasdaq Capital Market | USA |
 |
Aquestive Therapeutics
AQST
|
$ 3.78 | 0.43 % | $ 404 M | Nasdaq Global Market | USA |
 |
Global Blood Therapeutics
GBT
|
- | - | $ 4.62 B | Nasdaq Global Select Market,SPB | USA |
 |
Idera Pharmaceuticals
IDRA
|
- | -23.04 % | $ 26.6 M | Nasdaq Global Select Market | USA |
 |
Infinity Pharmaceuticals
INFI
|
- | -46.98 % | $ 3.57 M | Nasdaq Global Select Market | USA |
 |
Novan
NOVN
|
- | -24.84 % | $ 2.64 M | Nasdaq Capital Market | USA |
 |
NanoString Technologies
NSTG
|
- | -37.43 % | $ 5.1 M | Nasdaq Global Select Market | USA |
 |
Orgenesis
ORGS
|
- | -33.86 % | $ 61.2 M | Nasdaq Capital Market | USA |
 |
Humanigen
HGEN
|
- | -81.12 % | $ 4.28 M | Nasdaq Global Select Market | USA |
 |
Sorrento Therapeutics
SRNE
|
- | -29.58 % | $ 126 M | Nasdaq Global Select Market | USA |
 |
Surface Oncology
SURF
|
- | - | $ 59.7 M | Nasdaq Global Select Market | USA |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Jounce Therapeutics
JNCE
|
- | - | $ 98.4 M | Nasdaq Global Select Market | USA |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market |  Israel |
 |
Verona Pharma plc
VRNA
|
- | - | $ 69.7 B | Nasdaq Global Select Market |  Britain |
 |
Corner Growth Acquisition Corp.
COOL
|
- | -0.89 % | $ 114 M | Nasdaq Global Select Market | USA |
 |
MannKind Corporation
MNKD
|
$ 3.04 | 5.63 % | $ 929 M | Nasdaq Global Market | USA |
 |
Mersana Therapeutics
MRSN
|
- | - | $ 3.56 B | Nasdaq Global Select Market | USA |
 |
Evelo Biosciences
EVLO
|
- | -14.46 % | $ 27.9 M | Nasdaq Global Select Market | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
- | - | $ 384 M | Nasdaq Global Select Market | Britain |
 |
Morphic Holding
MORF
|
- | - | $ 2.42 B | Nasdaq Global Market | USA |
|
Monopar Therapeutics
MNPR
|
$ 69.27 | 1.42 % | $ 513 M | Nasdaq Global Select Market | USA |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |
 |
Genocea Biosciences
GNCA
|
- | -15.0 % | $ 3.04 M | Nasdaq Global Select Market | USA |
|
Amryt Pharma plc
AMYT
|
- | - | $ 621 M | Nasdaq Global Select Market | Britain |
 |
G1 Therapeutics
GTHX
|
- | - | $ 370 M | Nasdaq Global Select Market,SPB | USA |
 |
Milestone Pharmaceuticals
MIST
|
$ 0.71 | 0.84 % | $ 75.4 M | Nasdaq Global Select Market |  Canada |
 |
Kinnate Biopharma
KNTE
|
- | - | $ 123 M | Nasdaq Global Select Market | USA |
 |
Atossa Therapeutics
ATOS
|
$ 2.91 | 9.81 % | $ 25.1 M | Nasdaq Capital Market | USA |
 |
NexImmune
NEXI
|
- | 70.13 % | $ 4.12 M | Nasdaq Global Market | USA |